Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
<h4>Objectives</h4>Inflammation is involved in the pathogenesis of depression. A few cross-sectional population-based studies have found that depression is associated with increased levels of inflammatory markers. Soluble urokinase plasminogen activation receptor (suPAR) is known to be a...
Main Authors: | Eva Haastrup, Katrine Grau, Jesper Eugen-Olsen, Christian Thorball, Lars Vedel Kessing, Henrik Ullum |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0110555 |
Similar Items
-
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
by: Nina S. Godtfredsen, et al.
Published: (2018-05-01) -
Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
by: Per Wittenhagen, et al.
Published: (2011-08-01) -
Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
by: Per Wittenhagen, et al.
Published: (2011-01-01) -
Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
by: Thomas H. Haupt, et al.
Published: (2014-01-01) -
Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
by: Thomas H. Haupt, et al.
Published: (2014-12-01)